BAX

Over the past six months, Baxter's stock price has experienced significant declines and fluctuations. In February 2026, BAX shares tumbled 16% after reporting its Q4 results due to an unfavorable product mix, inventory adjustments, and higher manufacturing costs. In March 2026, the abrupt departure of Baxter's CFO was noted as a potentially confusing decline for the stock. In April 2026, Baxter reported its first-quarter 2026 results with sales from continuing operations increasing by 3%, but organic sales were down 1%. In May 2026, Baxter announced changes to its executive compensation and corporate governance following its 2026 annual meeting of stockholders.